Skip to main content

Investor information

Cash distributions

Year Cash distribution per share (in CHF) Ex-date Payment date
2019 7.50 10.09.2019 12.09.2019
2018 5.50
1.50
27.06.2018
19.09.2018
29.06.2018
21.09.2018
2017 5.80 28.06.2017 30.06.2017
2016 5.50 28.06.2016 30.06.2016
2015 5.50 01.07.2015 06.07.2015
2014 3.00 24.06.2014 27.06.2014
2013 1.50 04.09.2013 09.09.2013


Significant shareholders

Based on the notifications received by the Company, the following shareholders reported equity holdings in HBM Healthcare Investments Ltd of three percent or more as at 31 March 2019:

Shareholding Shareholder
15 - 20% Nogra Pharma Invest S.à.r.l., Luxemburg


 

See here for details about significant shareholders in HBM Healthcare Investments Ltd. (SIX Swiss Exchange).  

 

Fees

Management fees (paid quarterly):

0.75% of company assets plus
0.75% of the company's market capitalisation

Performance fee (paid annually):

15% on increase in value above the high water mark. High water mark (per share for all outstanding shares) for financial year 2019/2020: NAV of CHF 194.36.

 

Presentations

Analyst reports

 

Management transactions

See here for details about Management transactions in HBM Healthcare Investments' shares (SIX Swiss Exchange).

 

Articles of association

Articles of Association of HBM Healthcare Investments Ltd.

 

Share buy-back programmes

Share buy-back programme 2019

The maximum permissible daily repurchase volume in accordance with Art. 123 para. 1 lit. (c) FinfraV amounts to 1'203 shares.

HBM Healthcare Investments launches a new share buy-back programme

Rückkauf eigener Aktien zum Zweck der Kapitalherabsetzung (German)

Rachat d’actions propres dans le but d’une réduction de capital (French)

Transaction report share buy-back programme 2019

 

Share buy-back programme 2016 (completed)

The maximum permissible daily repurchase volume in accordance with Art. 123 para. 1 lit. (c) FinfraV amounts to 2'389 shares.

Bond issues

Bond tranches 2015-2021 and 2015-2023